Drug May Help Angina Patients Work Out

Ranexa eases chest pain that limits physical activity, study says

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

THURSDAY, April 29, 2004 (HealthDayNews) -- An investigational drug called Ranexa may offer relief to people with angina, a chronic condition that causes chest pain and limits physical activity, according to a new study.

It found the drug significantly increased the ability of angina patients to exercise. This study evaluated whether the drug was effective on its own and established the effective dosage amount.

The study appeared in a recent issue of the Journal of the American College of Cardiology.

A previous study found that when Ranexa was combined with current therapies to treat angina -- such as beta-blockers or calcium blockers -- it helped increase a patient's ability to exercise.

Ranexa is currently under review by the U.S. Food and Drug Administration.

More information

The U.S. National Heart, Lung, and Blood Institute has more about angina.

SOURCE: Saint Louis University Health Sciences Center, news release, April 2004

--

Last Updated: